摘要
目的探讨尿激酶对急性脑梗死患者的神经功能缺损改善的临床疗效。方法将2012年1月-2013年1月间我院收治的92例急性脑梗死患者随机分为观察组和对照组各46例，对照组采用常规治疗措施，观察组则在常规治疗基础上加用尿激酶溶栓治疗，对两组患者的疗效和神经功能缺损改善情况进行统计对比。结果观察组总有效率显著高于对照组，神经缺损功能评分恢复情况优于对照组，差异有统计学意义(P<0.05)。结论尿激酶溶栓治疗急性脑梗死疗效显著，相较于单纯采用常规治疗有着明显的优势，值得临床推广应用。
Abstract
Objective Clinical curative effect of nerve function defect discussion and study of urokinase on acute cerebral infarction to improve. Methods 2012.1-2013.1 of 92 patients in our hospital in patients with acute cerebral infarction were studied as objects, random the patients were divided into 46 cases of the observation group and 46 cases in the control group, the control group with conventional treatment, the observation group in the conventional therapy plus treatment with urokinase thrombolytic enzyme, and efficacy of nerve functional defect in two groups of patients with improved statistical contrast. Results The therapeutic, the total effective rate in the observation group were significantly higher than that of the control group; from the nerve function score recovery situation, the observation group was better than the control group, the difference was statistically significant(P<0.05). Conclusion The efficacy of thrombolytic therapy in acute cerebral infarction significantly, compared with simple conventional treatment has obvious advantages, is worthy of promotion and application in clinical.
NETL
NSTL
维普
万方数据